February 2, 2013
ZERO Co-PAY for Rebif® therapy
- /
Any eligible person with relapsing MS who is on Rebif® therapy may qualify for a $0 co-pay program available through…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
February 2, 2013
Survey: Caregivers of Spouses/Partners with MS Study
- /
Researchers at the University at Albany, SUNY are recruiting anyone who is the spouse/romantic partner of someone with MS to…
February 2, 2013
Investigators Recruiting for Personalized T Cell Immunotherapy Study in Secondary-Progressive MS –
- /
This study is currently recruiting participants. Verified November 2012 by Opexa Therapeutics, Inc. Study Purpose: The purpose of this study is…
February 2, 2013
BG-12 (Biogen’s Oral) NOW has a Name: TECFIDERA
- /
- /
- /
Tecfidera (BG-12) awaits FDA decision .. January 31, 2013 Tecfidera (BG-12) is pending FDA decision on March 27, 2013. This…
February 1, 2013
Injectable Drug Demonstrates Efficacy with Reduced Dosing Schedule
- /
An injectable treatment for relapsing-remitting MS (RRMS) designed to significantly reduce the dosing schedule typical of standard interferon drugs has…
January 30, 2013
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis
- /
- /
Androgenic hormones could help treat multiple sclerosis Paris- Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study…
January 30, 2013
Do you take LDN or have taken LDN and want to share your story?
- /
PO Box 1083, Buxton Norwich NR10 5WY Telephone: 0844 41 45 295 Email: [email protected] Web: www.ldnresearhctrust.org www.ldnaware.org Contact: Linda Elesgood…
January 29, 2013
Quantitative MRIs evade multiple sclerosis clinicoradiologic paradox
- /
- /
January 28, 2013 By Peter Sergo, medwireNews Reporter Quantitative magnetic resonance imaging (MRI) can detect microstructural changes in the spinal cords of…
January 29, 2013
Biogen says MS drug reduces relapse rates in study
- /
- /
Biogen says potential multiple sclerosis treatment reduces relapse rates in late-stage study Associated Press – Fri, Jan 25, 2013 WESTON, Mass. (AP)…
January 29, 2013
Genzyme: FDA will review Lemtrada, its drug candidate for relapsing MS
- /
- /
By Chris Reidy, Globe Staff Genzyme, now a Cambridge-based unit of French drug giant Sanofi SA., said Monday that the…
